00765nas a2200253   4500000000100000000000100001008004100002653001900043653002000062653002700082653002400109653002100133653002000154100001300174700001300187700001300200700001200213700001400225700001600239700001400255245021300269250001500482020001400497       2022                            d10aDPP4 inhibitor10aSGLT2 inhibitor10adiabetes complications10aObservational study10apopulation study10aType 2 diabetes1 aI. Idris1 aR. Zhang1 aJ. Mamza1 aM. Ford1 aT. Morris1 aA. Banerjee1 aK. Khunti00aSignificant reduction in chronic kidney disease progression with sodium-glucose cotransporter-2 inhibitors compared to dipeptidyl peptidase-4 inhibitors in adults with type 2 diabetes in a UK clinical setting  a2022/06/10  a1462-8902